Retatrutide 10 mg
€12.00 per mg
1 Products
Standard
€120,00
/each
3 Products
5% OFF
€114,00
/each
6 Products
10% OFF
€108,00
/each
8 Products
15% OFF
€102,00
/each
Secure payment via
'%3e%3cpath%20d='M780%200H0V500H780V0Z'%20fill='%231434CB'/%3e%3cpath%20d='M489.823%20143.111C442.988%20143.111%20401.134%20167.393%20401.134%20212.256C401.134%20263.706%20475.364%20267.259%20475.364%20293.106C475.364%20303.989%20462.895%20313.731%20441.6%20313.731C411.377%20313.731%20388.789%20300.119%20388.789%20300.119L379.123%20345.391C379.123%20345.391%20405.145%20356.889%20439.692%20356.889C490.898%20356.889%20531.19%20331.415%20531.19%20285.784C531.19%20231.419%20456.652%20227.971%20456.652%20203.981C456.652%20195.455%20466.887%20186.114%20488.122%20186.114C512.081%20186.114%20531.628%20196.014%20531.628%20196.014L541.087%20152.289C541.087%20152.289%20519.818%20143.111%20489.823%20143.111ZM61.3294%20146.411L60.1953%20153.011C60.1953%20153.011%2079.8988%20156.618%2097.645%20163.814C120.495%20172.064%20122.122%20176.868%20125.971%20191.786L167.905%20353.486H224.118L310.719%20146.411H254.635L198.989%20287.202L176.282%20167.861C174.199%20154.203%20163.651%20146.411%20150.74%20146.411H61.3294ZM333.271%20146.411L289.275%20353.486H342.756L386.598%20146.411H333.271ZM631.554%20146.411C618.658%20146.411%20611.825%20153.318%20606.811%20165.386L528.458%20353.486H584.542L595.393%20322.136H663.72L670.318%20353.486H719.805L676.633%20146.411H631.554ZM638.848%20202.356L655.473%20280.061H610.935L638.848%20202.356Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_6278_125833'%3e%3crect%20width='780'%20height='500'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Retatrutide research-grade lyophilized peptide powder in a glass vial. Retatrutide (LY3437943) is an investigational multi-receptor peptide agonist that targets GIP, GLP-1 and glucagon receptors, used in experimental models of obesity, glycemic control and metabolic regulation.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Technical Specifications
Frequently asked questions
Research Overview
Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously. It is used in laboratory and preclinical models to study integrated control of body weight, glucose homeostasis and whole-body energy balance.
Primary Research Areas
- Triple GIP/GLP-1/glucagon receptor agonism: mechanistic studies dissecting receptor pharmacology and downstream pathways.
- Obesity & body-weight regulation models: in vivo models exploring changes in body weight, adiposity, and food intake.
- Glycemic control & metabolic health: research on glucose tolerance, insulin dynamics, and hepatic glucose output.
More research on Retatrutide
Explore preclinical studies, mechanisms of action and references for Retatrutide.
View researchFor Research Use Only
This product is intended solely for in-vitro research and laboratory use. Not intended for human consumption, diagnostic or therapeutic purposes.
Safety & Handling
Handle with appropriate protective equipment (gloves, lab coat, eye protection). Store according to product specifications. Consult the Safety Data Sheet (SDS) for full safety instructions.